P Jimenez-Fonseca1, C Calderón2, R Hernández3, T Ramón Y Cajal4, M Mut5, A Ramchandani6, O Donnay7, A Carmona-Bayonas8. 1. Department of Medical Oncology, Hospital Universitario Central de Asturias, Av. Roma, s/n 33011, Oviedo, Asturias, Spain. palucaji@hotmail.com. 2. Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain. 3. Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. 4. Department of Medical Oncology, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain. 5. Department of Medical Oncology, Hospital Universitario Son Espases, Mallorca, Spain. 6. Department of Medical Oncology, Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain. 7. Department of Medical Oncology, Hospital Universitario La Princesa, Madrid, Spain. 8. Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.
Abstract
OBJECTIVE: Anxiety and depression affect cancer patients' quality of life. Our objectives were to determine the prevalence of anxiety and depression and analyze the association between positive psychological factors, sociodemographic factors, and clinical factors in oncological patients initiating adjuvant treatment. METHODS: A prospective, multicenter cohort of 600 consecutive patients completed the Brief Symptom Inventory, Mini-Mental Adjustment to Cancer, Life Orientation Scale-Revised, and Multidimensional Scale of Perceived Social Support questionnaires. RESULTS: Prevalence of anxiety and depression was 49.8 and 36.6%, respectively. Women and younger individuals were more anxious and depressed than men and seniors. Employed participants suffered more anxiety than retirees, and singles exhibited more depression than married or partnered subjects. Logistic regression analysis showed that hope, optimism, social support, being male, and older were significantly associated with a lower risk of anxiety and depression (p < 0.001). CONCLUSIONS: The high prevalence of anxiety and depression among Spaniards with cancer starting adjuvant chemotherapy suggests that more attention should be paid to mental health in these individuals. These findings are important for cancer patients because they can benefit from interventions that increase positive psychological factors such as hope, optimism, and social support to reduce anxiety and depression.
OBJECTIVE:Anxiety and depression affect cancerpatients' quality of life. Our objectives were to determine the prevalence of anxiety and depression and analyze the association between positive psychological factors, sociodemographic factors, and clinical factors in oncological patients initiating adjuvant treatment. METHODS: A prospective, multicenter cohort of 600 consecutive patients completed the Brief Symptom Inventory, Mini-Mental Adjustment to Cancer, Life Orientation Scale-Revised, and Multidimensional Scale of Perceived Social Support questionnaires. RESULTS: Prevalence of anxiety and depression was 49.8 and 36.6%, respectively. Women and younger individuals were more anxious and depressed than men and seniors. Employed participants suffered more anxiety than retirees, and singles exhibited more depression than married or partnered subjects. Logistic regression analysis showed that hope, optimism, social support, being male, and older were significantly associated with a lower risk of anxiety and depression (p < 0.001). CONCLUSIONS: The high prevalence of anxiety and depression among Spaniards with cancer starting adjuvant chemotherapy suggests that more attention should be paid to mental health in these individuals. These findings are important for cancerpatients because they can benefit from interventions that increase positive psychological factors such as hope, optimism, and social support to reduce anxiety and depression.
Entities:
Keywords:
Anxiety; Cancer; Depression; Hope; Optimism; Social support
Authors: Morgan S Lee; Dinorah Martinez Tyson; Brian D Gonzalez; Brent J Small; Suzanne C Lechner; Michael H Antoni; Andrea Vinard; Madeline Krause; Cathy Meade; Paul B Jacobsen Journal: Psychooncology Date: 2017-07-13 Impact factor: 3.894
Authors: Nancy K Janz; Mahasin S Mujahid; Sarah T Hawley; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2009-09-16 Impact factor: 4.442
Authors: L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz Journal: Br J Cancer Date: 2004-06-14 Impact factor: 7.640
Authors: I Ghanem; B Castelo; P Jimenez-Fonseca; A Carmona-Bayonas; O Higuera; C Beato; T García; R Hernández; C Calderon Journal: Clin Transl Oncol Date: 2019-05-10 Impact factor: 3.405
Authors: Jing Du; Matthijs Plas; Anthony R Absalom; Barbara L van Leeuwen; Geertruida H de Bock Journal: J Surg Oncol Date: 2020-01-12 Impact factor: 3.454
Authors: Caterina Calderon; Pere Joan Ferrando; Urbano Lorenzo-Seva; Raquel Hernández; Marta Oporto-Alonso; Paula Jiménez-Fonseca Journal: Int J Clin Health Psychol Date: 2020-01-15
Authors: Daniel Santa Mina; Stefanus J van Rooijen; Enrico M Minnella; Shabbir M H Alibhai; Priya Brahmbhatt; Susanne O Dalton; Chelsia Gillis; Michael P W Grocott; Doris Howell; Ian M Randall; Catherine M Sabiston; Julie K Silver; Gerrit Slooter; Malcolm West; Sandy Jack; Franco Carli Journal: Front Oncol Date: 2021-01-11 Impact factor: 6.244